Medtronic plc Files 8-K on Financials and Senior Notes

Ticker: MDT · Form: 8-K · Filed: Nov 19, 2024 · CIK: 1613103

Medtronic PLC 8-K Filing Summary
FieldDetail
CompanyMedtronic PLC (MDT)
Form Type8-K
Filed DateNov 19, 2024
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: debt, financials, notes

TL;DR

Medtronic dropped an 8-K detailing its debt maturities and interest rates on senior notes.

AI Summary

On November 19, 2024, Medtronic plc filed an 8-K report detailing its financial condition and results of operations. The filing includes information on various senior notes due in the coming years, such as those maturing in 2025, 2027, 2028, 2029, and 2031, with varying interest rates.

Why It Matters

This filing provides investors with an update on Medtronic's financial structure, specifically concerning its outstanding debt obligations, which can impact its financial health and future investment decisions.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.

Key Numbers

Key Players & Entities

FAQ

What specific interest rates are associated with the senior notes maturing in 2025?

The filing mentions senior notes due in 2025 with rates of A0.250%, A0.000%, and A2.625%.

Are there any new debt issuances mentioned in this 8-K filing?

This filing primarily details existing senior notes and their maturity dates and interest rates, rather than new issuances.

What is the fiscal year end for Medtronic plc?

Medtronic plc's fiscal year ends on 0425.

What is the accession number for this 8-K filing?

The accession number for this filing is 0001613103-24-000162.

What are the maturity dates for the senior notes with interest rates of A3.650% and A1.625%?

The senior notes with an interest rate of A3.650% mature in 2029, and those with an interest rate of A1.625% mature in 2031.

Filing Stats: 668 words · 3 min read · ~2 pages · Grade level 8.9 · Accepted 2024-11-19 06:46:38

Key Financial Figures

Filing Documents

02. Results of Operations and Financial Condition

Item 2.02. Results of Operations and Financial Condition On November 19, 2024, Medtronic plc, a public limited company organized under the laws of Ireland, issued a press release announcing its second quarter fiscal year 2025 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report.

01. Exhibits

Item 9.01. Exhibits. (d) List of Exhibits Exhibit Number Description 99.1 Press release of Medtronic plc, dated November 19, 2024 104 Cover Page Interactive Data File (embedded with the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Medtronic plc By /s/ Gary Corona Date: November 19, 2024 Gary Corona Senior Vice President and Interim Chief Financial Officer (Principal Financial Officer) EXHIBIT INDEX Exhibit Number Description 99.1 Press release of Medtronic plc, dated November 19, 2024 104 Cover Page Interactive Data File (embedded with the Inline XBRL document).

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing